SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
March 25, 2024 16:05 ET | Sanara MedTech Inc.
FORT WORTH, TX, March 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 23, 2024 17:10 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
February 22, 2024 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
February 13, 2024 16:00 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 13, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
SeaStar_SM_LogoCard.png
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
January 26, 2024 08:05 ET | SeaStar Medical Holding Corporation
DENVER, Jan. 26, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (the “Company”), a medical technology company developing proprietary solutions to reduce the consequences...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14
December 07, 2023 16:30 ET | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Dec. 07, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
SMT-Full-Horiz_CMYK-FullColor.jpg
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing
November 30, 2023 09:15 ET | Sanara MedTech Inc.
FORT WORTH, TX, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe
November 16, 2023 08:00 ET | NeuroOne Medical Technologies Corp
Patent allowance strengthens IP portfolio and positions company in pursuing drug delivery using its neural probes EDEN PRAIRIE, Minn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 14, 2023 17:15 ET | NeuroOne Medical Technologies Corp
Volker strengthens existing management team in areas of commercialization, business development, and reimbursement EDEN PRAIRIE, Minn., Nov. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical...
LOGO.png
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
November 13, 2023 16:14 ET | Nemaura Medical, Inc
Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...